Author: Bill Snyder
Feb. 6, 2020—Two Vanderbilt University pharmacologists have won prestigious awards from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
Feb. 6, 2020—Robert Carnahan, PhD, associate professor of Pediatrics and Radiology and Radiological Sciences, has been appointed associate director of the Vanderbilt Vaccine Center.
Feb. 6, 2020—Lisa Bastarache, MS, research assistant professor of Biomedical Informatics, and Tony Capra, PhD, associate professor of Biological Sciences and Biomedical Informatics, described the intersection of genetics and electronic health records during last week’s Cutting-Edge Discovery Lecture.
Feb. 6, 2020—Vanderbilt University biochemist Stanley Cohen, PhD, whose discovery of epidermal growth factor (EGF) and its receptor earned him a Nobel Prize and opened the door to a new class of cancer therapies, died Wednesday, Feb. 5, in Nashville. He was 97.
Jan. 23, 2020—Using part of an antibody isolated at Vanderbilt that “broadly neutralizes” the human dengue virus, biologists at the University of California San Diego and colleagues have disarmed the mosquito that transmits the disabling and potentially deadly tropical infection.
Jan. 16, 2020—VUMC researchers have created the world’s first laboratory model of precancerous changes in the lining of the stomach, a scientific tour de force that is helping to unlock the mysteries of gastric cancer development.
Dec. 31, 2019—Ege T. Kavalali, PhD, professor and acting chair of the Department of Pharmacology in the Vanderbilt University School of Medicine, has been elected a recipient of a prestigious Humboldt Research Award by the Alexander von Humboldt Foundation of Germany.